• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

五元杂环磺酰胺类碳酸酐酶抑制剂。

Five-Membered Heterocyclic Sulfonamides as Carbonic Anhydrase Inhibitors.

机构信息

NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, Sesto Fiorentino, 50019 Florence, Italy.

出版信息

Molecules. 2023 Apr 4;28(7):3220. doi: 10.3390/molecules28073220.

DOI:10.3390/molecules28073220
PMID:37049983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10096498/
Abstract

The development of heterocyclic derivatives has progressed considerably over the past decades, and many new carbonic anhydrase inhibitors (CAIs) fall into this field. In particular, five-membered heterocyclic sulfonamides have been generally shown to be more effective inhibitors compared to six-membered rings ones. Despite the importance of oxygen and nitrogen five-membered heterocyclic aromatic rings in medicinal chemistry, the installation of sulfonamide moiety on such heterocycles has not received much attention. On the other hand, 1,3,4-thiadiazole/thiadiazoline ring-bearing sulfonamides are the scaffolds which have been widely used in a variety of pharmaceutically important CAIs such as acetazolamide, metazolamide and their many derivatives obtained by using the tail approach. Here, we reviewed the field focusing on the diverse biological activities of these CAIs, such as antiglaucoma, antiepileptic, antitumor and antiinfective properties. This review highlights developments involving five-membered heterocyclic sulfonamides over the last years, with a focus on their pharmacological/clinical applications.

摘要

杂环衍生物的发展在过去几十年中取得了相当大的进展,许多新的碳酸酐酶抑制剂(CAIs)都属于这一领域。特别是,与六元环相比,五元杂环磺酰胺通常被证明是更有效的抑制剂。尽管含氧和氮的五元杂环芳环在药物化学中很重要,但磺酰胺部分在这些杂环上的安装并没有受到太多关注。另一方面,1,3,4-噻二唑/噻二嗪环取代的磺酰胺是骨架,已广泛用于各种具有重要药用价值的 CAIs 中,如乙酰唑胺、甲唑胺及其通过尾巴方法获得的许多衍生物。在这里,我们重点介绍了这些 CAIs 的多种生物活性,如抗青光眼、抗癫痫、抗肿瘤和抗感染特性。本综述强调了过去几年中涉及五元杂环磺酰胺的发展,重点介绍了它们的药理学/临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/5562bad084d4/molecules-28-03220-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/8ed96c9287d1/molecules-28-03220-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/be7e525628ab/molecules-28-03220-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/c00f4a7aa45e/molecules-28-03220-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/91fde41362b6/molecules-28-03220-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/d39777244f34/molecules-28-03220-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/dab711572a48/molecules-28-03220-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/3535db0ce1ec/molecules-28-03220-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/6034562c6e00/molecules-28-03220-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/94806684dac9/molecules-28-03220-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/eeb249a19b8e/molecules-28-03220-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/b9798e7b6638/molecules-28-03220-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/01fa60b43d96/molecules-28-03220-sch007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/84bbba990d42/molecules-28-03220-sch008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/84fb6740a71b/molecules-28-03220-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/49abdd62fc82/molecules-28-03220-sch009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/fa8874d37aca/molecules-28-03220-sch010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/3b65382ac127/molecules-28-03220-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/cb0d1e471ff3/molecules-28-03220-sch011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/b65340e33b88/molecules-28-03220-sch012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/18f88e6e2e25/molecules-28-03220-sch013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/0b2296f8a72d/molecules-28-03220-sch014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/58d3b5c961ff/molecules-28-03220-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/5562bad084d4/molecules-28-03220-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/8ed96c9287d1/molecules-28-03220-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/be7e525628ab/molecules-28-03220-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/c00f4a7aa45e/molecules-28-03220-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/91fde41362b6/molecules-28-03220-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/d39777244f34/molecules-28-03220-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/dab711572a48/molecules-28-03220-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/3535db0ce1ec/molecules-28-03220-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/6034562c6e00/molecules-28-03220-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/94806684dac9/molecules-28-03220-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/eeb249a19b8e/molecules-28-03220-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/b9798e7b6638/molecules-28-03220-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/01fa60b43d96/molecules-28-03220-sch007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/84bbba990d42/molecules-28-03220-sch008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/84fb6740a71b/molecules-28-03220-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/49abdd62fc82/molecules-28-03220-sch009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/fa8874d37aca/molecules-28-03220-sch010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/3b65382ac127/molecules-28-03220-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/cb0d1e471ff3/molecules-28-03220-sch011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/b65340e33b88/molecules-28-03220-sch012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/18f88e6e2e25/molecules-28-03220-sch013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/0b2296f8a72d/molecules-28-03220-sch014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/58d3b5c961ff/molecules-28-03220-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b1c/10096498/5562bad084d4/molecules-28-03220-g009.jpg

相似文献

1
Five-Membered Heterocyclic Sulfonamides as Carbonic Anhydrase Inhibitors.五元杂环磺酰胺类碳酸酐酶抑制剂。
Molecules. 2023 Apr 4;28(7):3220. doi: 10.3390/molecules28073220.
2
Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties.碳酸酐酶抑制剂:包含丙戊酰基和其他亲脂性基团的抗惊厥磺酰胺类药物。
J Med Chem. 2002 Jan 17;45(2):312-20. doi: 10.1021/jm0109199.
3
Carbonic anhydrase inhibitors. Inhibition of red blood cell ostrich (Struthio camelus) carbonic anhydrase with a series of aromatic and heterocyclic sulfonamides.碳酸酐酶抑制剂。用一系列芳香族和杂环磺胺类药物抑制鸵鸟(鸵鸟属骆驼)红细胞碳酸酐酶。
J Enzyme Inhib Med Chem. 2005 Aug;20(4):383-7. doi: 10.1080/14756360500141960.
4
Salts of 5-amino-2-sulfonamide-1,3,4-thiadiazole, a structural and analog of acetazolamide, show interesting carbonic anhydrase inhibitory properties, diuretic, and anticonvulsant action.5-氨基-2-磺酰胺基-1,3,4-噻二唑的盐类作为乙酰唑胺的结构类似物,具有有趣的碳酸酐酶抑制特性、利尿作用和抗惊厥作用。
J Enzyme Inhib Med Chem. 2016 Dec;31(6):1102-10. doi: 10.3109/14756366.2015.1096270. Epub 2015 Oct 26.
5
Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides.碳酸酐酶抑制剂:用芳香族/杂环磺酰胺文库对人跨膜同工酶XIV的抑制作用
Bioorg Med Chem. 2005 Nov 15;13(22):6089-93. doi: 10.1016/j.bmc.2005.06.022. Epub 2005 Jul 11.
6
In vitro inhibition effects of some new sulfonamide inhibitors on human carbonic anhydrase I and II.某些新型磺胺类抑制剂对人碳酸酐酶I和II的体外抑制作用。
J Enzyme Inhib Med Chem. 2004 Jun;19(3):257-61. doi: 10.1080/14756360410001689586.
7
Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?碳酸酐酶抑制剂。含阳离子或阴离子部分的水溶性、局部有效、降低眼压的芳香族/杂环磺酰胺的合成:尾部比环更重要吗?
J Med Chem. 1999 Jul 15;42(14):2641-50. doi: 10.1021/jm9900523.
8
Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.碳酸酐酶抑制剂。用芳香族和杂环磺酰胺抑制人胞质同工酶VII。
Bioorg Med Chem Lett. 2005 Feb 15;15(4):971-6. doi: 10.1016/j.bmcl.2004.12.052.
9
Carbonic anhydrase inhibitors: Schiff's bases of aromatic and heterocyclic sulfonamides and their metal complexes.碳酸酐酶抑制剂:芳香族和杂环磺酰胺的席夫碱及其金属配合物。
J Enzyme Inhib Med Chem. 2004 Jun;19(3):263-7. doi: 10.1080/14756360410001689595.
10
Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs.一系列SLC-0111类似物的合成及其对碳酸酐酶的抑制作用
Bioorg Med Chem. 2017 May 1;25(9):2569-2576. doi: 10.1016/j.bmc.2017.03.027. Epub 2017 Mar 18.

引用本文的文献

1
Discovery of a novel 4-pyridyl SLC-0111 analog targeting tumor-associated carbonic anhydrase isoform IX through tail-based design approach with potent anticancer activity.通过基于尾部的设计方法发现一种新型4-吡啶基SLC-0111类似物,其靶向肿瘤相关碳酸酐酶同工酶IX并具有强大的抗癌活性。
Front Chem. 2025 Apr 4;13:1571646. doi: 10.3389/fchem.2025.1571646. eCollection 2025.
2
Exploring the Inhibition of α-Carbonic Anhydrase by Sulfonamides: Insights into Potential Drug Targeting.探索磺胺类药物对α-碳酸酐酶的抑制作用:对潜在药物靶向性的见解
Int J Mol Sci. 2024 Dec 26;26(1):116. doi: 10.3390/ijms26010116.
3
Novel Dibenzoazepine-Substituted Triazole Hybrids as Cholinesterase and Carbonic Anhydrase Inhibitors and Anticancer Agents: Synthesis, Characterization, Biological Evaluation, and Studies.

本文引用的文献

1
Structural Characterization of Thiadiazolesulfonamide Inhibitors Bound to α-Carbonic Anhydrase.与α-碳酸酐酶结合的噻二唑磺酰胺抑制剂的结构表征
ACS Med Chem Lett. 2022 Dec 6;14(1):103-109. doi: 10.1021/acsmedchemlett.2c00471. eCollection 2023 Jan 12.
2
Discovery, Chemistry, and Preclinical Development of Pritelivir, a Novel Treatment Option for Acyclovir-Resistant Herpes Simplex Virus Infections.普瑞巴林的发现、化学结构和临床前开发:一种治疗阿昔洛韦耐药单纯疱疹病毒感染的新选择。
J Med Chem. 2022 Oct 27;65(20):13614-13628. doi: 10.1021/acs.jmedchem.2c00668. Epub 2022 Oct 6.
3
Development of Hydrogen Sulfide-Releasing Carbonic Anhydrases IX- and XII-Selective Inhibitors with Enhanced Antihyperalgesic Action in a Rat Model of Arthritis.
新型二苯并氮杂卓取代的三唑杂化物作为胆碱酯酶和碳酸酐酶抑制剂及抗癌剂:合成、表征、生物学评价及研究
ACS Omega. 2024 Nov 16;9(47):46860-46878. doi: 10.1021/acsomega.4c05804. eCollection 2024 Nov 26.
4
Non-fused Pyrimidine Derivatives as Potential Pharmacological Entities: A Review.作为潜在药理实体的非稠合嘧啶衍生物:综述
Curr Top Med Chem. 2025;25(9):1032-1068. doi: 10.2174/0115680266317088240924205745.
5
A Novel Compound from the Phenylsulfonylpiperazine Class: Evaluation of In Vitro Activity on Luminal Breast Cancer Cells.一种新型苯磺酰基哌嗪类化合物:对腔上皮乳腺癌细胞体外活性的评估。
Molecules. 2024 Sep 20;29(18):4471. doi: 10.3390/molecules29184471.
6
New 1,3,4-Thiadiazole Derivatives as α-Glucosidase Inhibitors: Design, Synthesis, DFT, ADME, and In Vitro Enzymatic Studies.新型1,3,4-噻二唑衍生物作为α-葡萄糖苷酶抑制剂:设计、合成、密度泛函理论、药物代谢动力学及体外酶学研究
ACS Omega. 2024 Feb 5;9(7):7480-7490. doi: 10.1021/acsomega.3c05854. eCollection 2024 Feb 20.
硫化氢释放碳酸酐酶 IX 和 XII 选择性抑制剂的开发及其在关节炎大鼠模型中的增强抗痛觉过敏作用。
J Med Chem. 2022 Oct 13;65(19):13143-13157. doi: 10.1021/acs.jmedchem.2c00982. Epub 2022 Sep 19.
4
Anti-obesity carbonic anhydrase inhibitors: challenges and opportunities.抗肥胖碳酸酐酶抑制剂:挑战与机遇。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):2478-2488. doi: 10.1080/14756366.2022.2121393.
5
Inhibitors of Mitochondrial Human Carbonic Anhydrases VA and VB as a Therapeutic Strategy against Paclitaxel-Induced Neuropathic Pain in Mice.线粒体人碳酸酐酶 VA 和 VB 抑制剂作为治疗紫杉醇诱导的小鼠神经病理性疼痛的策略。
Int J Mol Sci. 2022 Jun 2;23(11):6229. doi: 10.3390/ijms23116229.
6
Biological activity of oxadiazole and thiadiazole derivatives.恶二唑和噻二唑衍生物的生物活性。
Appl Microbiol Biotechnol. 2022 May;106(9-10):3489-3505. doi: 10.1007/s00253-022-11969-0. Epub 2022 May 14.
7
Anti-viral activity of thiazole derivatives: an updated patent review.噻唑衍生物的抗病毒活性:最新专利研究综述。
Expert Opin Ther Pat. 2022 Jul;32(7):791-815. doi: 10.1080/13543776.2022.2067477. Epub 2022 Apr 27.
8
5-(Sulfamoyl)thien-2-yl 1,3-oxazole inhibitors of carbonic anhydrase II with hydrophilic periphery.5-(磺胺酰基)噻吩-2-基 1,3-恶唑类碳酸酐酶 II 抑制剂,具有亲水外围。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):1005-1011. doi: 10.1080/14756366.2022.2056733.
9
The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII.三尾策略作为一种提高磺胺类抑制剂对肿瘤相关碳酸酐酶 IX 和 XII 作用选择性的新策略。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):930-939. doi: 10.1080/14756366.2022.2053526.
10
Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of .将美国食品和药物管理局批准的磺胺类碳酸酐酶抑制剂重新用于治疗 。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):51-61. doi: 10.1080/14756366.2021.1991336.